Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Aris

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 1, 1997
The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcomeR M Aris, P H Gilligan, I P Neuringer, et al.
American Journal of Respiratory Cell and Molecular Biology|September 9, 1998
Immune cells in a mouse airway model of obliterative bronchiolitisI P Neuringer, R B Mannon, T M Coffman, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2000
Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantationR M Aris, G E Lester, J B Renner, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1996
Ozone-induced decrements in FEV1 and FVC do not correlate with measures of inflammationJ R Balmes, L L Chen, C Scannell, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 1996
Greater ozone-induced inflammatory responses in subjects with asthmaC Scannell, L Chen, R M Aris, et al.
Annals of Internal Medicine|February 7, 1998
Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosisR M Aris, J B Renner, A D Winders, et al.
The American Journal of Clinical Nutrition|March 10, 2001
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patientsR K Lark, G E Lester, D A Ontjes, et al.
Thorax|April 8, 2006
Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantationW Chalermskulrat, N Sood, I P Neuringer, et al.
The Annals of Thoracic Surgery|September 2, 1998
Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk groupT M Egan, F C Detterbeck, M R Mill, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2000
Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosisR M Aris, A R Stephens, D A Ontjes, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
American Journal of Respiratory and Critical Care Medicine|May 1, 1997
The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcomeR M Aris, P H Gilligan, I P Neuringer, et al.
American Journal of Respiratory Cell and Molecular Biology|September 9, 1998
Immune cells in a mouse airway model of obliterative bronchiolitisI P Neuringer, R B Mannon, T M Coffman, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2000
Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantationR M Aris, G E Lester, J B Renner, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 1996
Ozone-induced decrements in FEV1 and FVC do not correlate with measures of inflammationJ R Balmes, L L Chen, C Scannell, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 1996
Greater ozone-induced inflammatory responses in subjects with asthmaC Scannell, L Chen, R M Aris, et al.
Annals of Internal Medicine|February 7, 1998
Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosisR M Aris, J B Renner, A D Winders, et al.
The American Journal of Clinical Nutrition|March 10, 2001
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patientsR K Lark, G E Lester, D A Ontjes, et al.
Thorax|April 8, 2006
Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantationW Chalermskulrat, N Sood, I P Neuringer, et al.
The Annals of Thoracic Surgery|September 2, 1998
Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk groupT M Egan, F C Detterbeck, M R Mill, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2000
Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosisR M Aris, A R Stephens, D A Ontjes, et al.
Pageof 3